QA: Pear Therapeutics Inc. in us_health_services/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001835567_2023_Pear_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001835567, Pear Therapeutics Inc.

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 15,683,000
2 AssetsCurrent 72,959,000
3 PropertyPlantAndEquipment 6,076,000
4 remainder_Assets 411,000
5 LongTermLiabilities 8,717,000
6 LiabilitiesCurrent 49,442,000
7 remainder_Liabilities 6,385,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 8,182,000
10 GeneralAndAdministrativeExpense 79,551,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 48,311,000
16 remainder_Expenses 0
17 remainder_Revenues 12,694,000
18 remainder_NetIncome 47,859,000
19 remainder_ComprehensiveNetIncome -46,000
  yvar yval
0 Assets 95,129,000
1 Liabilities 64,544,000
2 Expenses 136,044,000
3 Revenues 12,694,000
4 StockholdersEquity 30,585,000
5 NetIncome -75,491,000
6 ComprehensiveNetIncome -75,537,000
7 BaseVar 210,604,095
8 EconomicCapitalRatio -0.611

Edgar->Model Mapping

Feature Distribution

Change over Time